Applicability of Somatic Mutation Signature in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-small Cell Lung Cancer Patients With Different Clinical Variables. This evidence concerns the gene ALK and non-small cell lung carcinoma.